Allicin can also inhibit angiogenesis in lung cancer cells (A549) by decreasing VEGF-A protein expression, suppressing VEGF-A gene expression, targeting the HIF pathway, and enhancing immune system activity [135]. The gene discussed is VEGFA; the disease is lung cancer.